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Objectives: The nitrate reductase assay (NRA) 
assay was recently approved by WHO for rapid 
rifampicin and isoniazid susceptibility testing of 
Mycobacterium tuberculosis. A modiﬁ cation of the 
technique is proposed, which consists in employing 
a multi-well plate format and enriched agar medium. 
The objective of this study is to evaluate the plate-
NRA directly on sputum samples (D-NRA) for early 
detection of extensively drug-resistant (XDR-TB). 
Methods: This preliminary study is currently 
performed in Buenos Aires, Argentina. Smear-
positive sputum samples from 26 consecutive TB 
patients at risk of treatment failure were assayed. 
Sputa were decontaminated with NALC-NaOH. 
Rifampicin, isoniazid, oﬂ oxacin, kanamycin, amikacin 
and capreomycin were tested at 1, 0.2, 2, 6, 2, and 
5 µg/ml, respectively, in 24-well plates containing 
Middlebrook 7H11-KNO
3
 agar. P-nitrobenzoic acid 
(PNB) was used for differentiating M. tuberculosis 
from other mycobacteria, and PRA-hsp65 was used 
as species identiﬁ cation reference method. Accuracy, 
turnaround time and cost were evaluated using the 
MGIT 960 system as gold standard method. 
Results: Out of 26 samples, 2 were both MGIT 
and NRA negative. The other 24 were identiﬁ ed 
as M. tuberculosis complex by both PNB test and 
PRA-hsp65. One NRA result for capreomycin was 
indeterminate and one isoniazid well was found 
contaminated. As for the remaining results, only one 
discordance was observed between both methods. 
The sensitivity and the speciﬁ city of the D-NRA was 
100% for all drugs except for capreomycin with a 
sensitivity of 100% and a speciﬁ city of 94.7%. The 
detection rate on day 14 was 50% for D-NRA and 9.5% 
for MGIT. Mean time to results was 16.5 and 21.9 days, 
respectively (P: <0.001). The local cost of supplies 
per sample was US$24.7 for D-NRA and US$50.5 for 
MGIT. 
Conclusion: Advantages of this fast colorimetric plate 
version include simpliﬁ cation of media dispensing 
and/inoculation procedures, and reduction of storage/
incubation space. Plate-NRA is simple and appears 
to be accurate to detect XDR-TB. In comparison with 
the MGIT system, D-NRA was faster and cheaper. 
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The global tuberculosis (TB) threat is difﬁ cult to 
evaluate in countries with scarce laboratory facilities 
where little is known about the genetic basis of drug 
resistance, including the rpoB RRDR (rifampicin 
resistance determining region) of the Mycobacterium 
tuberculosis complex (MTC). The present study 
aimed at performing a preliminary evaluation of rpoB 
polymorphisms in a DNA set of MTC isolates from 
Guinea-Bissau patients.
Ninety-four sputum specimens (74 bleach processed 
and 20 unprocessed) were sent to Lisbon for molecular 
analysis (n=94) and drug susceptibility testing (n=20). 
A 369bp region of the rpoB gene (including the 
81bp RRDR), was ampliﬁ ed. Sequencing was used 
as the gold standard for the identiﬁ cation of point 
mutations.
Two polymorphisms were identiﬁ ed: The alteration 
S531L, present in 3.2% of the specimens, and a 
new mutation, present in 28.7%, corresponding to 
nucleotide and amino acid polymorphism C224T 
and S469L, respectively, detected upstream from 
the RRDR, and not associated with RMP resistance. 
An NCBI BLAST revealed M. tuberculosis K85 
(M. africanum) as the only strain presenting this 
polymorphism.
The circulation of S531L mutated stains, associated 
with RMP resistance, points to the urgent need to 
further investigate RMP resistance in this African 
region. Moreover, the strains presenting the S469L 
polymorphism showed no other mutations suggesting 
that its role on RMP susceptibility/ resistance or in 
